109 related articles for article (PubMed ID: 25683927)
1. SEMA5A in Parkinson's disease.
Sand PG
Eur Rev Med Pharmacol Sci; 2015; 19(2):182-3. PubMed ID: 25683927
[No Abstract] [Full Text] [Related]
2. Meta analysis of the association of rs7702187 SNP in SEMA5A gene with risk of Parkinson's disease.
Yu X; Wang F; Zhang JP
Eur Rev Med Pharmacol Sci; 2014; 18(6):900-4. PubMed ID: 24706317
[TBL] [Abstract][Full Text] [Related]
3. LINGO1 gene analysis in Parkinson's disease phenotypes.
Lorenzo-Betancor O; Samaranch L; García-Martín E; Cervantes S; Agúndez JA; Jiménez-Jiménez FJ; Alonso-Navarro H; Luengo A; Coria F; Lorenzo E; Irigoyen J; Pastor P;
Mov Disord; 2011 Mar; 26(4):722-7. PubMed ID: 21506150
[TBL] [Abstract][Full Text] [Related]
4. [Correlation study of semaphorin 5a with risk of Parkinson's disease in a Chinese Han population].
Dong HR; Hua Y; Ding XS
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1589-92. PubMed ID: 19957501
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Neurosci Lett; 2006 May; 399(1-2):121-3. PubMed ID: 16481103
[TBL] [Abstract][Full Text] [Related]
6. LINGO1 rs9652490 and rs11856808 are not associated with the risk of Parkinson's disease: results of a meta-analysis.
Agúndez JA; Lorenzo-Betancor O; Pastor P; García-Martín E; Luengo A; Alonso-Navarro H; Jiménez-Jiménez FJ
Parkinsonism Relat Disord; 2012 Jun; 18(5):657-9. PubMed ID: 21955595
[No Abstract] [Full Text] [Related]
7. Association analysis of polymorphisms in VMAT2 and TMEM106B genes for Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy.
Hu T; Chen Y; Ou R; Wei Q; Cao B; Zhao B; Wu Y; Song W; Chen X; Shang HF
J Neurol Sci; 2017 Jun; 377():65-71. PubMed ID: 28477711
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the TMEM230 gene in familial Parkinson's disease from south Italy.
Procopio R; Gagliardi M; Nicoletti G; Morelli M; Annesi G; Quattrone A
J Neurol Sci; 2019 Sep; 404():16-18. PubMed ID: 31323517
[No Abstract] [Full Text] [Related]
9. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of TARDBP in Parkinson's disease.
van Blitterswijk M; van Es MA; Verbaan D; van Hilten JJ; Scheffer H; van de Warrenburg BP; Veldink JH; van den Berg LH
Neurobiol Aging; 2013 May; 34(5):1517.e1-3. PubMed ID: 23062702
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease: piecing together a genetic jigsaw.
Dekker MC; Bonifati V; van Duijn CM
Brain; 2003 Aug; 126(Pt 8):1722-33. PubMed ID: 12805097
[TBL] [Abstract][Full Text] [Related]
12. Additional support for the association of SLITRK1 var321 and Tourette syndrome.
O'Roak BJ; Morgan TM; Fishman DO; Saus E; Alonso P; Gratacòs M; Estivill X; Teltsh O; Kohn Y; Kidd KK; Cho J; Lifton RP; State MW
Mol Psychiatry; 2010 May; 15(5):447-50. PubMed ID: 20351724
[No Abstract] [Full Text] [Related]
13. Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients.
Guimarães Bde C; Pereira AC; Rodrigues Fda C; dos Santos AV; Campos M; dos Santos JM; dos Santos FL; de Rosso AL; Nicaretta DH; Pereira JS; da Silva DJ; Della Coletta MV; Santos-Rebouças CB; Pimentel MM
Parkinsonism Relat Disord; 2012 Jun; 18(5):688-9. PubMed ID: 22192918
[No Abstract] [Full Text] [Related]
14. From GWAS to clinical utility in Parkinson's disease.
Klein C; Ziegler A
Lancet; 2011 Feb; 377(9766):613-4. PubMed ID: 21292316
[No Abstract] [Full Text] [Related]
15. The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.
Shahmohammadibeni N; Rahimi-Aliabadi S; Jamshidi J; Emamalizadeh B; Shahmohammadibeni HA; Zare Bidoki A; Akhavan-Niaki H; Eftekhari H; Abdollahi S; Shekari Khaniani M; Shahmohammadibeni M; Fazeli A; Motallebi M; Taghavi S; Ahmadifard A; Shafiei Zarneh AE; Andarva M; Dadkhah T; Khademi E; Alehabib E; Rahimi M; Tafakhori A; Atakhorrami M; Darvish H
Neurol Sci; 2016 May; 37(5):731-6. PubMed ID: 26732583
[TBL] [Abstract][Full Text] [Related]
16. Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease.
Clarimon J; Scholz S; Fung HC; Hardy J; Eerola J; Hellstrom O; Chen CM; Wu YR; Tienari PJ; Singleton A
Am J Hum Genet; 2006 Jun; 78(6):1082-4; author reply 1092-4. PubMed ID: 16685660
[No Abstract] [Full Text] [Related]
17. Genetic risk loci for Parkinson's disease: Moving from state to trait?
Kasten M; Klein C
Mov Disord; 2015 May; 30(6):747-9. PubMed ID: 25907561
[No Abstract] [Full Text] [Related]
18. Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9.
Lu S; Zhou J
Neurosci Bull; 2017 Feb; 33(1):115-117. PubMed ID: 27743341
[TBL] [Abstract][Full Text] [Related]
19. Shaking the genome: new studies reveal genetic risk for Parkinson's disease.
Bonifati V
Lancet Neurol; 2010 Feb; 9(2):136-8. PubMed ID: 20129160
[No Abstract] [Full Text] [Related]
20. [Epidemiology and causes of Parkinson's disease].
Lill CM; Klein C
Nervenarzt; 2017 Apr; 88(4):345-355. PubMed ID: 28289797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
